$AMBS News Amarantus Fundamentals Are Improving
Post# of 144493
Posted On: 12/16/2013 2:27:35 PM
$AMBS News
Amarantus Fundamentals Are Improving 10:27 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:24 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus' LymPro May Be More Crucial For Alzheimer's Treatment Than We Think 7:38 a.m. Oct. 25, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 3:08 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Initiating Coverage Of Amarantus - Credibility vs. Perception - Analyst Blog 12:10 p.m. May 23, 2013 - Zacks.com
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 10:27 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:25 p.m. April 26, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: AMARANTUS BIOSCIENCE HOLDINGS, INC. 3:55 p.m. April 18, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:13 a.m. April 17, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus Obtains Exclusive Option to License University of Miami Bascom Palmer Eye Institute's Intellectual Property for the Treatment of Retinal Diseases Using MANF and CDNF 8:00 a.m. Dec. 3, 2013 - GlobeNewswire
Amarantus BioScience to Present at the LD Micro Sixth Annual Conference on December 3, 2013 9:20 a.m. Nov. 26, 2013 - GlobeNewswire
Amarantus Reports Third Quarter 2013 Financial Results and Development Progress 4:15 p.m. Nov. 14, 2013 - GlobeNewswire
Exclusive Insight on ITEN, MSLP and AMBS 4:21 a.m. Nov. 14, 2013 - ACCESSWIRE
Amarantus and Brewer Sports Announce 2nd #C4CT Concussion Awareness Summit Surrounding Super Bowl XLVIII 10:17 a.m. Nov. 13, 2013 - GlobeNewswire
Amarantus BioScience CSO Publishes New Blog Entitled "The Golden Goose: Preparing PhenoGuard to Lay the Next Golden Egg" 11:06 a.m. Nov. 12, 2013 - ACCESSWIRE
Stocks Under Review - WTER, BRGO, AMBS and TDEY 1:47 a.m. Nov. 8, 2013 - ACCESSWIRE
Amarantus Appoints David A. Lowe, PhD to Board of Directors 7:30 a.m. Nov. 6, 2013 - GlobeNewswire
Amarantus BioScience President and CEO Publishes New Blog Entitled "LymPro Heading into 2014: Shifting the Diagnostic Paradigm in Alzheimer's" 11:06 a.m. Nov. 4, 2013 - ACCESSWIRE
Amarantus Relocates Headquarters to Janssen Labs @QB3 Incubator in San Francisco 10:31 a.m. Oct. 30, 2013 - GlobeNewswire
New Equity Reports on AMBS, MDMN, ECPN and LJPC 12:32 a.m. Oct. 25, 2013 - ACCESSWIRE
Amarantus to Present at 6th Annual Livingston Securities Life Science Stakeholders Summit 8:00 a.m. Oct. 16, 2013 - GlobeNewswire
Amarantus Announces Positive Analytical Performance Data for LymPro Test(R) for Alzheimer's Disease 11:10 a.m. Oct. 14, 2013 - GlobeNewswire
Exclusive Video Interviews With CEOs Now on Equities.com: AHRO, AMBS, MTST, ONCS, TRGM 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
Amarantus Enters Into Letter of Intent With Renishaw for Convection-Enhanced Delivery of MANF in Parkinson's Disease 7:45 a.m. Oct. 3, 2013 - GlobeNewswire
Amarantus BioScience President and CEO Publishes New Blog Entitled â??Financial Stability Heading into 2014: Laying the Groundwork for an Up-listingâ? 9:59 a.m. Sept. 30, 2013 - ACCESSWIRE
Amarantus to Present at 2013 Aegis Healthcare Conference 7:45 a.m. Sept. 24, 2013 - GlobeNewswire
Amarantus Appoints F. Randall Grimes, MBA as Director of Sponsored Research 10:17 a.m. Sept. 13, 2013 - GlobeNewswire
Amarantus CEO to Present at the 15th Annual Rodman & Renshaw Global Investor Conference 8:53 a.m. Sept. 9, 2013 - GlobeNewswire
Amarantus Bioscience Holdings Announces Private Placement of Convertible Debentures and Warrants 8:25 a.m. Sept. 4, 2013 - GlobeNewswire
Amarantus Fundamentals Are Improving 10:27 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:24 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus' LymPro May Be More Crucial For Alzheimer's Treatment Than We Think 7:38 a.m. Oct. 25, 2013 - Seeking Alpha
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 3:08 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Initiating Coverage Of Amarantus - Credibility vs. Perception - Analyst Blog 12:10 p.m. May 23, 2013 - Zacks.com
10-Q: AMARANTUS BIOSCIENCE HOLDINGS, INC. 10:27 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: AMARANTUS BIOSCIENCE HOLDINGS, INC. 4:25 p.m. April 26, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: AMARANTUS BIOSCIENCE HOLDINGS, INC. 3:55 p.m. April 18, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: AMARANTUS BIOSCIENCE HOLDINGS, INC. 5:13 a.m. April 17, 2013 - Edgar Online - (EDG = 10Q, 10K)
Amarantus Obtains Exclusive Option to License University of Miami Bascom Palmer Eye Institute's Intellectual Property for the Treatment of Retinal Diseases Using MANF and CDNF 8:00 a.m. Dec. 3, 2013 - GlobeNewswire
Amarantus BioScience to Present at the LD Micro Sixth Annual Conference on December 3, 2013 9:20 a.m. Nov. 26, 2013 - GlobeNewswire
Amarantus Reports Third Quarter 2013 Financial Results and Development Progress 4:15 p.m. Nov. 14, 2013 - GlobeNewswire
Exclusive Insight on ITEN, MSLP and AMBS 4:21 a.m. Nov. 14, 2013 - ACCESSWIRE
Amarantus and Brewer Sports Announce 2nd #C4CT Concussion Awareness Summit Surrounding Super Bowl XLVIII 10:17 a.m. Nov. 13, 2013 - GlobeNewswire
Amarantus BioScience CSO Publishes New Blog Entitled "The Golden Goose: Preparing PhenoGuard to Lay the Next Golden Egg" 11:06 a.m. Nov. 12, 2013 - ACCESSWIRE
Stocks Under Review - WTER, BRGO, AMBS and TDEY 1:47 a.m. Nov. 8, 2013 - ACCESSWIRE
Amarantus Appoints David A. Lowe, PhD to Board of Directors 7:30 a.m. Nov. 6, 2013 - GlobeNewswire
Amarantus BioScience President and CEO Publishes New Blog Entitled "LymPro Heading into 2014: Shifting the Diagnostic Paradigm in Alzheimer's" 11:06 a.m. Nov. 4, 2013 - ACCESSWIRE
Amarantus Relocates Headquarters to Janssen Labs @QB3 Incubator in San Francisco 10:31 a.m. Oct. 30, 2013 - GlobeNewswire
New Equity Reports on AMBS, MDMN, ECPN and LJPC 12:32 a.m. Oct. 25, 2013 - ACCESSWIRE
Amarantus to Present at 6th Annual Livingston Securities Life Science Stakeholders Summit 8:00 a.m. Oct. 16, 2013 - GlobeNewswire
Amarantus Announces Positive Analytical Performance Data for LymPro Test(R) for Alzheimer's Disease 11:10 a.m. Oct. 14, 2013 - GlobeNewswire
Exclusive Video Interviews With CEOs Now on Equities.com: AHRO, AMBS, MTST, ONCS, TRGM 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
Amarantus Enters Into Letter of Intent With Renishaw for Convection-Enhanced Delivery of MANF in Parkinson's Disease 7:45 a.m. Oct. 3, 2013 - GlobeNewswire
Amarantus BioScience President and CEO Publishes New Blog Entitled â??Financial Stability Heading into 2014: Laying the Groundwork for an Up-listingâ? 9:59 a.m. Sept. 30, 2013 - ACCESSWIRE
Amarantus to Present at 2013 Aegis Healthcare Conference 7:45 a.m. Sept. 24, 2013 - GlobeNewswire
Amarantus Appoints F. Randall Grimes, MBA as Director of Sponsored Research 10:17 a.m. Sept. 13, 2013 - GlobeNewswire
Amarantus CEO to Present at the 15th Annual Rodman & Renshaw Global Investor Conference 8:53 a.m. Sept. 9, 2013 - GlobeNewswire
Amarantus Bioscience Holdings Announces Private Placement of Convertible Debentures and Warrants 8:25 a.m. Sept. 4, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼